Discover and read the best of Twitter Threads about #Mounjaro
Most recents (3)
The word ‘#obese’ is now considered unacceptable by the world’s academic community and should be changed by the @WHO to #obesity - because: a person has a disease called obesity and that person is NOT the disease itself. @pattynece @Eggface @PaulDavidsonPhD @ConscienHealth
A very interesting thread on @Reddit with @Walgreens employees and others discussing the rules made by @LillyPad to only place through prescriptions with the diagnosis of #diabetes - #Mounjaro is NOT YET indicated by the @US_FDA for #obesity as a diagnosis
The stigma for #obesity is directed at those with the disease. Unfortunately our society perceives that obesity is a “second class” disease and should be treated as such. Here @Walgreens employees are admitting to discriminating against patients 1/
Obesity Market Overview
A deep dive into the unmet need, competitive landscape and future of treatment:
A deep dive into the unmet need, competitive landscape and future of treatment:
Obesity primer:
• Defined as BMI >30kg/m^2
• >750M patients globally, including ~40% of US adults --> expected to increase to 1B people / ~50% of US adults by 2030
• Linked to 1/5 US adult deaths
However, just ~2% of people (15M) are on anti-obesity medications (AOM)
• Defined as BMI >30kg/m^2
• >750M patients globally, including ~40% of US adults --> expected to increase to 1B people / ~50% of US adults by 2030
• Linked to 1/5 US adult deaths
However, just ~2% of people (15M) are on anti-obesity medications (AOM)
Obesity is the leading risk factor for diabetes & other metabolic diseases
For years, bariatric surgery was the primary interventional treatment (25-30% weight loss) as opposed to 1st gen drugs (5-8% weight loss)
Emerging therapies have closed this efficacy gap
For years, bariatric surgery was the primary interventional treatment (25-30% weight loss) as opposed to 1st gen drugs (5-8% weight loss)
Emerging therapies have closed this efficacy gap
